Phibro Animal Health

Phibro Animal Health Corp. engages in the manufacture and supply of animal health and mineral nutrition products. It operates through the following segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment consists of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment produces specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.

Earnings data Q1 2023

Earnings data Q2 2023

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Barclays Global Healthcare Conference. Chief Financial Officer Damian Finio will address financial analysts and investors on Thursday, March 15, 2023, at 10:45 AM ET at the Loews Miami Beach Hotel. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com.

Phibro Animal Health Corporation to Participate in Barclays Global Healthcare Conference

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) announced today it will participate in the Bank of America 2023 Virtual Animal Health Summit. Chief Financial Officer Damian Finio and Executive Vice President, Corporate Strategy Daniel Bendheim will address financial analysts and investors on Thursday, March 2, 2023, at 10:50 AM ET. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.

Phibro Animal Health Corporation to Participate in Bank of America 2023 Animal Health Summit

Growing uptake of MFAs, dairy products and vaccines contributed to Phibro's (PAHC) Q2 revenues.

Phibro (PAHC) Q2 Earnings Top Estimates, Gross Margin Up

Phibro Animal Health Corporation (NASDAQ:PAHC ) Q2 2023 Earnings Conference Call February 9, 2023 9:00 AM ET Company Participants Damian Finio - Chief Financial Officer Jack Bendheim - Chairman, President and CEO Daniel Bendheim - Director and Executive Vice President, Corporate Strategy Conference Call Participants Brian Wright - ROTH MKM Operator Good morning. My name is Jeannie, and I will be your conference operator today.

Phibro Animal Health Corporation (PAHC) Q2 2023 Earnings Call Transcript

Phibro (PAHC) delivered earnings and revenue surprises of 13.33% and 2.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Phibro Animal Health (PAHC) Q2 Earnings and Revenues Beat Estimates

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its second quarter ended December 31, 2022. Highlights for the three months ended December 31, 2022 (compared to the three months ended December 31, 2021) Net sales of $244.6 million, an increase of $11.9 million, or 5% Net income of $7.2 million, a decrease of $10.3 million, or 59% Diluted EPS of $0.18, a decrease of $0.

Phibro Animal Health Corporation Reports Second Quarter Results

TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today announced the appointment of Alejandro Bernal, DVM, MS, MBA, as a Class III director of the Company, effective immediately. Mr. Bernal will be an independent director. His appointment fills a current vacancy and increases Board membership to nine directors, 6 of whom are independent directors.

Phibro Animal Health Corporation Announces the Appointment of Alejandro Bernal to Its Board of Directors and Declares Quarterly Dividend

Phibro (PAHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Phibro Animal Health (PAHC) to Report a Decline in Earnings: What to Look Out for

Pzena Investment Management

Fintel reports that Pzena Investment Management Llc has filed a 13G/A form with the SEC disclosing ownership of 1,969,236 shares of Phibro Animal Health Corp (PAHC).

Pzena Investment Management Ups Stake in Phibro Animal Health

TEANECK, N.J.--( BUSINESS WIRE )--Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its second quarter financial results on Wednesday, February 8, 2023, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 9, 2023, at 9:00 AM Eastern Time.

Phibro Animal Health Corporation to Host Webcast and Conference Call on December 2022 Quarterly Financial Results

Phibro's (PAHC) growing uptake of MFAs, dairy products and vaccines buoys optimism.

Phibro (PAHC) Q1 Earnings Miss Estimates, Sales Surpass

Phibro Animal Health Corporation (NASDAQ:PAHC ) Q1 2023 Earnings Conference Call November 10, 2022 9:00 AM ET Company Participants Damian Finio - Chief Financial Officer Jack Bendheim - Chairman, President and CEO Daniel Bendheim - Director and Executive Vice President, Corporate Strategy Conference Call Participants Erin Wright - Morgan Stanley Wolf Chanoff - Bank of America Operator Hello and thank you for standing by. My name is Regina, and I will be your conference operator today.

Phibro Animal Health Corporation (PAHC) Q1 2023 Earnings Call Transcript

Phibro (PAHC) delivered earnings and revenue surprises of -19.23% and 3.71%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Phibro Animal Health (PAHC) Misses Q1 Earnings Estimates

Phibro Animal Health Corporation Reports First Quarter Results, Revised Guidance

Phibro Animal Health Corporation Declares Quarterly Dividend

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its first quarter financial results on Wednesday, November 9, 2022, after the market closes. Phibro management will host a conference call and webcast on Thursday, November 10, 2022, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (88

Phibro Animal Health Corporation to Host Webcast and Conference Call on September 2022 Quarterly Financial Results

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

Phibro (PAHC) Down 18.4% Since Last Earnings Report: Can It Rebound?

BELLA VISTA, Australia--(BUSINESS WIRE)--This spring, Phibro Animal Health introduced RelyOn™ feed additive, a new solution to help support rumen health, animal efficiency and performance. Now, the alternative natural product has received validation from the Carbon Trust, a global climate consultancy, for its ability to reduce methane emissions. The validation is based on results from laboratory and on-farm testing against a valid baseline. Based on these test results, the Carbon Trust validate

The Carbon Trust Validates Greenhouse Gas Effects of Phibro Feed Additive

Price competition coming from cheap generic alternatives of a few Phirbo (PAHC) products is a deterrent.

Phirbo (PAHC) Faces Rising Costs and Inflationary Pressure

Elanco Animal Health Inc

Freshpet

IDEXX Laboratories

Zoetis

Despite inflationary pressures that are increasing the price of goods across the board, consumers are still pampering their pets when it comes to food.

5 Pet Care Stocks Gurus Love

Phibro (PAHC) posts better-than-expected revenues for the fiscal fourth quarter, with robust growth across all segments.

Phibro (PAHC) Q4 Earnings Miss Estimates, Sales Surpass

Phibro Animal Health Corporation (NASDAQ:PAHC ) Q4 2022 Earnings Conference Call August 25, 2022 9:00 AM ET Company Participants Damian Finio - CFO Jack C. Bendheim - Chairman, President, and CEO Daniel M.

Phibro Animal Health Corporation (PAHC) Q4 2022 Earnings Call Transcript

Phibro (PAHC) delivered earnings and revenue surprises of -10% and 0.98%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Phibro Animal Health (PAHC) Q4 Earnings Lag Estimates

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) (“Phibro” or the “Company”) today announced financial results for its fourth quarter and fiscal year ended June 30, 2022, and provided financial guidance for the year ending June 30, 2023. Highlights for the three months ended June 30, 2022 (compared to the three months ended June 30, 2021) Net sales of $255.3 million, an increase of $35.0 million, or 16% Net income of $7.5 million, a decrease of $9.6 million, or 56%

Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year Results, Provides Financial Guidance

TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq:PAHC) announced today it will participate in the Morgan Stanley Global Healthcare Conference being held at the Sheraton New York. Chief Financial Officer Damian Finio and Executive Vice President, Corporate Strategy Daniel Bendheim will address financial analysts and investors on Wednesday, September 14, 2022, at 9:10 AM ET. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Rela

News for Phibro Animal Health Stock (PAHC)